Non-ablative 1,550 nm fractional laser t
β
Bas S. Wind; Marije W. Kroon; Arne A. Meesters; Johan F. Beek; J.P. Wietze van d
π
Article
π
2010
π
John Wiley and Sons
π
English
β 128 KB
## Abstract ## Background Melasma is a uichronic, often relapsing skin disorder, with poor longβterm results from all current therapies. ## Objective To assess efficacy and safety of nonβablative 1,550βnm fractional laser therapy (FLT) as compared to the gold standard, triple topical therapy (TT